Septal Solutions, Inc. has announced a new offering to raise $10 million through a Simple Agreement for Future Equity (SAFE). The filing, submitted on October 27, 2026, indicates that the company has already secured approximately $7.3 million, leaving about $2.7 million still available for potential investors.

This move is significant as it highlights the company's efforts to secure funding in a competitive health care landscape. The company's transition from its previous name, Excision Medical, Inc., to Septal Solutions, Inc. reflects a strategic rebranding aimed at enhancing its market presence.

Background

Septal Solutions, Inc. is incorporated in Delaware and operates out of Exton, Pennsylvania. The company is categorized under the "Other Health Care" industry group. The recent filing is part of its ongoing efforts to raise capital, with previous filings indicating a consistent approach to funding through private offerings.

What the Filing Says

The filing states, "Rule 506(b) provides a 'safer harbor' for a private offering," which underscores the regulatory framework the company is utilizing for this capital raise. The total offering amount is set at $10 million, with $7.3 million already sold to investors.

Impact

This offering may affect a total of 29 investors who have already participated in the funding round. The absence of non-accredited investors indicates that the company is targeting a specific group of accredited investors for this offering.

What's Next

The filing does not say what happens next, but the company is likely to continue its efforts to attract the remaining funds and further develop its business strategy.